Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology

Seferović, Petar M., Petrie, Mark C., Filippatos, Gerasimos S., Anker, Stefan D., Rosano, Giuseppe, Bauersachs, Johann, Paulus, Walter J., Komajda, Michel, Cosentino, Francesco, de Boer, Rudolf A., Farmakis, Dimitrios, Doehner, Wolfram, Lambrinou, Ekaterini, Lopatin, Yuri, Piepoli, Massimo F., Theodorakis, Michael J., Wiggers, Henrik, Lekakis, John, Mebazaa, Alexandre, Mamas, Mamas A., Tschöpe, Carsten, Hoes, Arno W., Seferović, Jelena P., Logue, Jennifer, McDonagh, Theresa, Riley, Jillian P., Milinković, Ivan, Polovina, Marija, van Veldhuisen, Dirk J., Lainscak, Mitja, Maggioni, Aldo P., Ruschitzka, Frank, McMurray, John J.V.·2018·European Journal of Heart Failure
DOI 10.1002/ejhf.1170

Cited by (704)

Items 501–600 of 704

  1. Evolution of the prevalence of the cardiorenal continuum in hospitalized patients with type 2 diabetes in real clinical practice (experience of Moscow City Clinical Hospital No. 52 of Moscow Health Department)
    Mikhail Borisovich Antsiferov, Mariana A. Lysenko, Т. Н. Маркова, E.M. Zeltyn-Abramov, N.I. Belavina, M.A. Ovchinnikova, Anastasia A. Anchutina, I.A. Ivanova · 2023 · Endocrinology News Opinions Training
  2. EXPECTATIVAS DOS ESTUDANTES DE ODONTOLOGIA ACERCA DO MERCADO DE TRABALHO E PERCEPÇÃO SOBRE O PERFIL PROFISSIONAL PARA ATUAÇÃO NO SISTEMA PÚBLICO DE SAÚDE
    Milena dos Santos Silva, Poliana Santos Pereira, Emilly Jamilly Medeiros de Menezes, Vanessa Stephane de Oliveira Araújo, Patrícia Helena Costa Mendes, João Gabriel Silva Souza · 2022
  3. Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
    Giulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, Tommaso Bucci, Marco Proietti, Min Qian, Yineng Chen, John L.P. Thompson, Shunichi Homma, Gregory Y.H. Lip et al. · 2024 · Internal and Emergency Medicine
  4. Серцева недостатність зі збереженою фракцією викиду: основні молекулярні і клітинні механізми розвитку
    A.M. Sokolova, VIKTOR V. PUSHKAREV, LIUBOV K. SOKOLOVA, V.M. Pushkarev, Mykola D. Tronko · 2024 · Ukrainian Journal of Cardiology
  5. Positive Correlation between BMI and Left Ventricle and Atrium Inside Diameter Size in Chinese Type 2 Diabetes Patients with Left Ventricular and Atrial Enlargement
    Jie Zhang, Zhenhua Yang, Xiaoxiang Fan, Qiuping Fei, Yingfei Xi · 2024 · Reviews in Cardiovascular Medicine
  6. Significance of plasma TGF-b1 level detection in patients with T2DM with heart failure
    Yunjing Sun, Bo Miao, Yabing Cao, Jiangman Cui, Yingxiao Da, Liping Qi, Song Zhou · 2024 · Journal of Medical Biochemistry
  7. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
    José Antonio Gimeno Orna, Ana Belén Mañas Martínez, Luis Rodrı́guez Padial, Manuel Anguita Sánchez, Vivencio Barrios, Javier Muñiz García, Antonio Pérez · 2024 · Endocrinología Diabetes y Nutrición (English ed )
  8. Assessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care
    Francesco Lapi, Ettore Marconi, Gerardo Medea, Iacopo Cricelli, Damiano Parretti, Alessandro Rossi, Claudio Alberto Cricelli · 2025 · Endocrine
  9. Type 2 diabetes increases the risk of mortality and cardiovascular events in ischemic HFmrEF patients: a retrospective cohort study
    Zhican Liu, Hailong Hu, Jianping Zeng, Mingyan Jiang · 2025 · Diabetology & Metabolic Syndrome
  10. Association Between Type 2 Diabetes Mellitus and Heart Failure: A Retrospective Study from a Tertiary Care Diabetes Centre in India
    Rajendra Pradeepa, Thyparambil Aravindakshan Pramodkumar, Ranjit Mohan Anjana, Saravanan Jebarani, Abdul Subhan Naziyagulnaaz, Sadasivam Ganesan, Natarajan Premananth, Abraham Oomman, Soumitra Kumar, Pathiyil Balagopalan Jayagopal et al. · 2025 · Diabetes Therapy
  11. Peculiarities of carbohydrate and lipid changes in the case of different variants of the unwanted overcoming of heart defects in patients with coronary heart disease in combination with type 2 diabetes
    Ekaterina Lipakova · 2019 · Problems of Uninterrupted Medical Training and Science
  12. Heart Failure Association Position Papers – A New Way to Advance the Field
    Andrew J.S. Coats · 2019 · European Journal of Heart Failure
  13. Features of Bcl2 and p53 proteins synthesis in pancreatic islets of normotensive and hypertensive rats with streptozotocin-induced diabetes
    Т. V. Аbramova, Тарас Васильович Іваненко, Ольга Валеріївна Мельникова · 2019 · Pathologia
  14. Prevention of type 2 diabetes in patients with chronic heart failure
    Е.П. Павликова, A. G. Sorokina, A. V. Potapenko · 2020 · Clinical pharmacology and therapy
  15. Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes
    Edoardo Mannucci, Pier Paolo Mangia, Lorenzo Pradelli · 2020 · Farmeconomia Health economics and therapeutic pathways
  16. Improvement of renal function after transcatheter aortic valve replacement and its impact on survival
    Dominik Kylies, Sandra Freitag‐Wolf, Florian Fulisch, Hatim Seoudy, Christian Kühn, Lars Kihm, Thomas Puehler, Georg Lutter, Astrid Dempfle, Norbert Frey et al. · 2021 · BMC Nephrology
  17. Management of Patients with Chronic Heart Failure and Diabetes Mellitus
    Elena Vladimirovna Reznik, Thanh Luan Nguyen, G. N. Golukhov · 2021 · Rational Pharmacotherapy in Cardiology
  18. Patients characteristics and prognostic implications of type 2 diabetes mellitus in heart failure with preserved, mid-rang reduced and reduced ejection fraction
    Marija Mrvošević, Marija M. Polovina · 2021 · Medicinski podmladak
  19. Niosome-carvedilol protects DNA damage of supraphysiologic concentrations of insulin using comet assay: An in vitro study
    Marzieh Farahani-Zangaraki, Azade Taheri, Mahmoud Etebari · 2021 · Human & Experimental Toxicology
  20. PET imaging in diabetic cardiomyopathy
    Antti Saraste, Juhani M. Knuuti · 2021 · Elsevier eBooks
  21. Clinical Application of Metformin Use in Anhui Province, China: A Cross-Sectional Study
    Li Chen, Qin Chen, Xueping Chen, Pengli Zhu, Meinan Chen, Wei Wang, Shandong Ye, Mao Sheng Zheng · 2023 · Journal of Multidisciplinary Healthcare
  22. Effects of Liraglutide on Diastolic Function Parameters in Patients with Type 2 Diabetes and Coronary Heart Disease
    传统 王 · 2023 · Advances in Clinical Medicine
  23. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
    Giuseppe M.C. Rosano, Piotr P. Ponikowski, Cristiana Vitale, Stefan D. Anker, Javed Butler, Vincent Fabien, Gerasimos S Filippatos, Bridget‐Anne Kirwan, Iain C. Macdougall, Marco Metra et al. · 2023 · Cardiovascular Diabetology
  24. Risk of Heart Failure in Diabetic Patients Receiving Sulfonylureas
    Olga Vaccaro, Gabriele Riccardi, Aldo Pietro Maggioni · 2018 · European Journal of Heart Failure
  25. Comment on ‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al.
    Nadja Scherbakov, Wolfram Doehner · 2020 · Journal of Cachexia Sarcopenia and Muscle
  26. A simple way to spotlight hidden heart failure in type 2 diabetes?
    Gian Paolo Fadini, Angelo Avogaro · 2021 · European Journal of Heart Failure
  27. Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes
    Petar M Seferovic, Marija M. Polovina, Jelena P. Seferović, Giuseppe M.C. Rosano · 2022 · International Journal of Cardiology
  28. Cardiovascular Events and Heart Failure in Patients with Type 2 Diabetes Treated with Dipeptidyl Peptidase-4 Inhibitors: An Update Systematic Review and Meta-Analysis
    Adili Tuersun, Guanxin Hou, Gang Cheng · 2023 · SSRN Electronic Journal
  29. Exploring Racial and Ethnic Differences in Diabetic Cardiomyopathy
    Maya E. Guglin, Dustin Hillerson · 2024 · Journal of the American College of Cardiology
  30. Diabetes Mellitus and Chronic Heart Failure
    Jindřich Špinar, Lenka Špinarová, Jiří Vítovec · 2019 · Vnitřní lékařství
  31. May 2018 at a Glance: The Central Role of Co-Morbidities
    Marco Metra · 2018 · European Journal of Heart Failure
  32. Diabetes mellitus and heart failure: insights from a toxic relationship
    Moritz Hundertmark, Eleanor C. Wicks · 2018 · Practical Diabetes
  33. Preventing Heart Failure in Diabetes
    Adam D. DeVore, Jennifer B. Green · 2018 · JACC Heart Failure
  34. Das diabetische Herz und Herzinsuffizienz – Aktuelles zu Entstehung und Therapie
    Elric Zweck, Julia Szendrödi, Malte Kelm, Michael Roden · 2019 · DMW - Deutsche Medizinische Wochenschrift
  35. Selección de lo mejor del año 2018 en cardiología clínica
    Carlos Escobar, Juan Cosín, Marisol Bravo, Adriana Saltijeral, Martín Ruiz Ortiz, Vivencio Barrios · 2019 · REC CardioClinics
  36. Selección de lo mejor del año 2018 en riesgo vascular y rehabilitación cardiaca
    Pablo Toledo Frías, Raquel Campuzano Ruíz, José Antonio Alarcón Duque, Alejandro Berenguel Senén, María Rosa Fernández Olmo, Manuel Abeytua Jiménez · 2019 · REC CardioClinics
  37. Figures of the Heart Failure Association: Petar M. Seferović, President, 2018–2020
    Andrew J.S. Coats · 2019 · European Journal of Heart Failure
  38. Clinical case: heart failure and ischaemic heart disease
    Giuseppe M.C. Rosano · 2019 · European Heart Journal Supplements
  39. Heart Failure Atlas, a Major Project of the Heart Failure Association in Concert with the European Society of Cardiology
    Andrew J.S. Coats · 2019 · European Journal of Heart Failure
  40. Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure
    Pasquale Perrone Filardi, Eduardo Bossone · 2019 · Heart Failure Clinics
  41. August 2019 at a Glance: Arrhythmogenic Cardiomyopathy, Biomarkers of Inflammation, Insulin Treatment, Initiation of Sacubitril/Valsartan, and Pharmacy-Based Intervention to Increase Medication Adherence
    Marco Metra · 2019 · European Journal of Heart Failure
  42. October 2019 at a Glance: Epidemiology, Prevention, and Modes of Death
    Marianna Adamo, Carlo Lombardi, Marco Metra · 2019 · European Journal of Heart Failure
  43. The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
    M Melville · 2019 · British Journal of Cardiac Nursing
  44. Treatment of Patients with Heart failure and Type 2 Diabetes: a review of the literature
    Elisa Fabbri, Maurizio Nizzoli · 2019 · Italian Journal of Medicine
  45. Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control
    Petar M Seferovic, Pardeep S. Jhund · 2019 · European Heart Journal Supplements
  46. 2 tipo cukrinio diabeto vadyba Lietuvos pirminėje sveikatos priežiūroje
    Aida Budrevičiūtė, Ramuné Kalèdiené, Renata Paukštaitienė, Skirmantė Sauliūnė, Leonas Valius, Aida Budrevičiūtė · 2019 · Sveikatos politika ir valdymas
  47. 7. Diabetes and Heart Failure: How to Treat Doubles Dangers
    Hiroshi Ito · 2019 · Nihon Naika Gakkai Zasshi
  48. Srdcové zlyhávanie a diabetes mellitus. Nebezpečné spojenie / Heart failure and diabetes mellitus. Dangerous association
    Eva Gonçalvesová · 2020 · Cardiology letters
  49. Relation of Glycosylated Hemoglobin and Obesity Indices with Diastolic Dysfunction in Participants with Type 2 Diabetes Mellitus
    Virendra Chandrashekhar Patil, Aniket Avhad · 2020 · Journal of Medical Sciences
  50. Diabetes e Insuficiencia Cardíaca
    Walter Alarco · 2020 · Archivos Peruanos de Cardiología y Cirugía Cardiovascular
  51. July 2020 at a Glance: Focus on Imaging and Cardiomyopathies
    Daniela Tomasoni, Marianna Adamo, Marco Metra · 2020 · European Journal of Heart Failure
  52. A novel paradigm for heart failure with preserved ejection fraction
    Ilona Cuijpers · 2020 · Research Publications (Maastricht University)
  53. Herzinsuffizienzprotektion bei Patienten mit Diabetes mellitus Typ 2 durch SGLT2-Inhibitoren – Evidenzlage und mögliche Mechanismen
    Andreas J. Rieth, Christian W. Hamm, Christoph Wanner, Veselin L. Mitrović, Till Keller · 2020 · Herz
  54. September 2020 at a Glance: Focus on Heart Failure with Preserved Ejection Fraction and Medical Therapy
    Daniela Tomasoni, Marianna Adamo, Marco Metra · 2020 · European Journal of Heart Failure
  55. New Treatment Options to Reduce Heart Failure Hospitalization
    Zoltán Papp, Attila Tóth · 2020 · ESC Heart Failure
  56. Challenging and opportunities in clinical implementation of circulating cardiac biomarkers in diabetes mellitus: the narrative review
    Alexander Е. Berezin, Alexander A. Berezin · 2021 · AME Medical Journal
  57. The association of diurnal blood glucose variability with subclinical cardiac disease in patients with type 2 diabetes mellitus
    Walid A. Shehab-Eldin, Ahmed Al-ashmawy, Mahmoud Kamel, Nesrin Elhelbawy, Alaaeldin Abdelsalam Dawood, Mostafa Mohamed Elnajjar · 2020 · Journal of the Saudi Heart Association
  58. Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention and Treatment of Heart Failure
    Nasser E. Mikhail · 2019 · Journal of Endocrinology and Thyroid Research
  59. Az SGLT2-gátló kezelés evidenciái a csökkent ejekciós frakcióval járó szívelégtelenség terápiájában
    Róbert Sepp · 2020 · Cardiologia Hungarica
  60. Management of heart failure in the context of type 2 diabetes
    Antonio Arturo Fernandez, Graham Paul Shaw · 2021 · Elsevier eBooks
  61. A Network Meta-Analysis of the Efficacy and Safety of Empagliflozin at Different Doses in Patients with Diabetes Mellitus Based on Randomized Controlled Trials
    Qian Wu, Chen Liao, Mengyu He, Can Li, Fang Zou, Lei Hu, Yiping Wei, Wenxiong Zhang · 2020
  62. Diabetes and Heart Failure
    Eun‐Jung Rhee · 2021 · Cardiovascular Prevention and Pharmacotherapy
  63. Chronické srdeční selhání - důležité téma pro internisty
    Hana Rosolová · 2018 · Vnitřní lékařství
  64. Das kardiorenale Syndrom ist die häufigste erste kardiovaskuläre Manifestation beim Typ-2-Diabetes und mit erhöhter Mortalität assoziiert: eine große multinationale Beobachtungsstudie
    KI Birkeland, D Anderson, Johan Bodegård, JW Eriksson, Anna Norhammar, Marcus Thuresson, Marc Pignot, Elena Garal‐Pantaler, Y Toshitaka, K Issei et al. · 2021 · Diabetologie und Stoffwechsel
  65. Efectividad del ejercicio físico en pacientes con prediabetes sobre el control glucémico: Protocolo para una revisión sistemática
    Hernández Bermúdez, Ivonne Carolina · 2021
  66. Bidirectional associations in comorbid diseases
    Farid Ismagilievich Belyalov · 2021 · Clinical Medicine (Russian Journal)
  67. Impact of Residual B-lines at Discharge on Outcome of Heart Failure Patients（IMP-OUTCOME)
    Yunlong Zhu, Na Li, Zhiliu Peng, Mingxing Wu, Haobo Huang, Wenjiao Zhao, Liqing Yi, Min Liao, Zhican Liu, Yiqun Peng et al. · 2021 · Research Square
  68. Characteristics that influence the diagnosis and treatment of diabetes in geriatric patients over 75
    Angelo Scuteri · 2021 · Journal of Gerontology and Geriatrics
  69. SGLT-2 INHIBITORS – AN ANTIDIABETIC WITH CARDIOPROTECTIVE EFFECTS
    Mrinal Kanti Guha · 2021 · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
  70. Prognostic Implication of Admission HbA1c for All-cause Mortality in Ischemic Heart Failure Among a Chinese Population: A Prospective Cohort Study
    Weida Qiu, Sicheng Chen, Anping Cai, Xiaoju Xiao, Zhiping Gao, Jijin Lin, Liwen Li · 2021 · Research Square
  71. Terapia inhibitorami kontransportera sodowo-glukozowego 2 – nie tylko dla diabetologów
    Maria Sawościan, Małgorzata Lelonek · 2021 · Folia Cardiologica
  72. Management of a Patient with Severe Hypotension and Advanced Heart Failure with Reduced Left Ventricular Ejection Fraction
    M. S. Bychkova, Elena Vladimirovna Reznik · 2022 · The Russian Archives of Internal Medicine
  73. Újdonságok a dapagliflozinról: a DECLARE-TIMI 58 vizsgálat alcsoport-elemzései
    Zoltán Balogh · 2019 · Diabetologia Hungarica
  74. Effect of diabetes mellitus on long-term outcomes of patients with ischemic heart disease and left ventricular dysfunction undergoing surgical revascularization: a propensity score-matching study
    meng liu, Huajun Zhang, Han Soo Song, Nan Cheng, Yuan-Bin Wu, Rong Wang · 2020
  75. The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
    Martin Mellville · 2019 · Journal of Prescribing Practice
  76. NODULAR THERAPY AS A WAY TO TREAT COMORBID DISEASES (LITERATURE REVIEW)
    Valentyna O. Sribna, T.S. Dochak, Tetyana Yu. Voznesenska, Т. В. Блашків · 2022 · Bulletin of Problems Biology and Medicine
  77. ASSISTÊNCIA DE ENFERMAGEM HUMANIZADA NO PROCESSO DO PARTO NORMAL: UMA REVISÃO INTEGRATIVA DA LITERATURA
    Gabriel Costa Vieira, Letícia Sousa do Nascimento, Rosângela Maria da Silva Souza, Guilherme Henrique Nascimento Alves, Isabelle Guerreiro de Oliveira, Rainny Beatriz Sabóia de Oliveira, Thays Queiroz Santos, Laís Araújo Tavares Silva, Aline Ouriques de Gouveia, Amanda Ouriques de Gouveia et al. · 2022
  78. LEFT VENTRICULAR DIASTOLIC FUNCTION ABNORMALITIES IN PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS
    Najia Aslam Soomro, Kamran Ahmed Khan, Shahid Ahmed, Rubina Rauf, Iram Jehan Balouch, Syed Taha Ali, Muhammad Nauman Khan · 2022 · Pakistan Heart Journal
  79. EFFICIENCY OF CARDIO- AND NEPHROPROTECTION OF DIFFERENT ANTIHYPER- TENSIVE DRUGS COMBINATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Е. С. Крутиков, R. O. Akaev, V. A. Tsvetkov · 2022 · Таврический медико-биологический вестник
  80. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
    Katharina Lechner, Matthias Böck, Clemens von Schacky, Johannes Scherr, Elke Lorenz, Benjamin Lechner, Bernhard Haller, Alexander Krannich, Martin Halle, Rolf Wachter et al. · 2022 · Research Square
  81. Malnutrition management of hospitalized patients with diabetes/hyperglycemia and heart failure
    Ana Zugasti Murillo, M a Jesús Chinchetru, R. Burgos, José Manuel García Almeida, Pilar Matía-Martín, Samara Palma Milla, Alejandro Sanz París, José Joaquín Alfaro Martínez, Ana Artero Fullana, Alfonso Jesús Calañas Continente et al. · 2022 · Nutrición Hospitalaria
  82. EFFECTIVENESS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC HEART FAILURE
    Tetiana I. Liadova, Вовк К.В., Власенко О.О., Liudmila L. Sherstiuk, Кратенко Г.С., Мартиненко М.В. · 2023 · World Science
  83. Effects of dapagliflozin on cardiac function indexes and serum MCP-1 levels in patients with Type 2 diabetes mellitus complicated with heart failure
    Xianpei Zhang, Yang Yang, Weizhe Xiao, Jing Liu, Xiaojun Zhang, Ke Chen, Wenliang Xiao, Chuanqiang Wang · 2023 · Biotechnology and Genetic Engineering Reviews
  84. SGLT2 inhibitors effects on cardiac function and plasma biomarkers of diabetic patients with preserved ejection fraction
    Marcelino Cortés, Oscar Lorenzo Gonzalez, Jairo Lumpuy‐Castillo, Sacramento Martínez-Albaladejo, Mikel Taibo Urquía, Ana María Pello Lázaro, Jose Antonio Bollas Becerra, Miguel Orejas, Miguel Ángel Navas Lobato, Ester Macia Palafox et al. · 2023 · Research Square
  85. The Article Presents a Clinical Case of Successful Use of Neoton in a Patient With Decompensated Chronic Heart Failure
    S. N. Тereschenko, Alfiya A. Safiullina · 2023 · Kardiologiia
  86. The Chronic Systolic Heart Failure Patient: Presentation and Management
    Abbas Bitar, Keith D. Aaronson · 2023 · Wiley eBooks
  87. APTIDÃO FÍSICA, SAÚDE MENTAL E NUTRIÇÃO NO ADOLESCENTE
    Leonardo Pereira da Silva, Gustavo de Sá Oliveira Lima, Diandra Carvalho de Sá Noleto, Marcos Antonio do Nascimento · 2023
  88. EXERCÍCIO FÍSICO E ANSIEDADE NO ADOLESCENTE
    André Scotti Rabelo, Karina Hellen de Souza de Oliveira, Lucas Miquéias Silva Abreu, Michele Brito Correia, FELIPE BISPO RIBEIRO · 2023
  89. Exercício físico e saúde do adolescente
    Carlos José Moraes Dias, Carlos Alberto Alves Dias Filho, Cristiano Teixeira Mostarda, Herikson Araújo Costa · 2023
  90. DEFINIÇÕES E CLASSIFICAÇÃO DA ADOLESCÊNCIA
    Manuelly Estefanny Vieira Pereira, Nathaniel Gomes Oliveira, Paulo Ricardo Ferreira Ribeiro, Thais Marcelle Campos da Silva, Carlos José Moraes Dias · 2023
  91. ASPECTOS ETIOPATOGÊNICOS DO CÂNCER DE TESTÍCULO EM ADOLESCENTES E SEU IMPACTO NA SAÚDE MENTAL
    Carlos Alberto Alves Dias Filho, Fernanda Diógenes Ferreira, Flávia Rafaela Diógenes Ferreira, João Guilherme Patriota Carneiro, José Carlos Gomes Patriota Neto, Maria Eduarda Silva Cardoso · 2023
  92. EXERCÍCIO FÍSICO E ADOLESCÊNCIA
    Nivaldo de Jesus Silva Soares, Flávio de Oliveira Pires, Lilian Fernanda Pereira Cavalcante · 2023
  93. COMPORTAMENTO PARENTAL ASSOCIADO A FATORES DE RISCO CARDIOVASCULAR EM ADOLESCENTES
    Herikson Araújo Costa, André Scotti Rabelo, Vicenilma de Andrade Martins Costa, Francisco Eduardo Lopes da Silva, Bruno Fernando Pereira Pinto · 2023
  94. ASPECTOS E FATORES ASSOCIADOS À OBESIDADE NA ADOLESCÊNCIA
    Leonardo Hesley Ferraz Durans, Thamyres da Cruz Miranda, Helen Nara da Silva e Silva, Ellian Robert Vale Santos, Saimon Leitão, Cristiano Teixeira Mostarda · 2023
  95. DIABETES MELLITUS TIPO 2 EM ADOLESCENTES E OS RISCOS DO DESENVOLVIMENTO DE INSUFICIÊNCIA CARDÍACA
    Carlos Alberto Alves Dias Filho, Rodrigo Guimarães Vieira de Carvalho, João Guilherme Patriota Carneiro, José Carlos Gomes Patriota Neto, Lara Teles Sousa Rocha, Paula Athaicy Veras Rodrigues · 2023
  96. HIPERTENSÃO ARTERIAL NO ADOLESCENTE
    Nivaldo de Jesus Silva Soares, Flávio de Oliveira Pires, Lilian Fernanda Pereira Cavalcante · 2023
  97. TREINAMENTO DE FORÇA, CRESCIMENTO E DESENVOLVIMENTO EM CRIANÇAS E ADOLESCENTES
    Raphael Furtado Marques, Rachel Melo Ribeiro · 2023
  98. МЕТОДИ ЛІКУВАННЯ СЕРЦЕВОЇ НЕДОСТАТНОСТІ НА ФОНІ ІНФАРКТУ МІОКАРДА З ПОЄДНАНИМ ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ
    Yuliia A. Spivak · 2023 · Перспективи та інновації науки
  99. THE CONTRIBUTION OF COMORBID DISEASES TO TYPE 2 DIABETES MELLITUS IN HOSPITALIZED PATIENTS
    Galina Milyukova, Песков Андрей Борисович, Mikhail Pavlovich Khokhlov, Elena Evgen'evna Yudina, Tat'yana Sergeevna Golubtsova, Irina Rinatovna Kerova, Natal'ya Manina, Svetlana Alekseevna Pribylova · 2023 · Современные проблемы науки и образования
  100. Vitamin D attenuates diabetic myocardial injury via the Erbb4/ferroptosis axis
    Hanlu Song, Yufan Miao, Yujing Zhang, Luoya Zhang, Hao Chen, Lulu Tang, Wenjie Li, Chenxi Gu, Xing Li · 2023 · bioRxiv (Cold Spring Harbor Laboratory)